#44: Obesity Medication Overview from AACE 2017

Master the safe and effective use of obesity medications with Endocrinologist, Dr. Karl Nadolsky (co-author of 2016 AACE Obesity guidelines), Director of the Diabetes, Obesity & Metabolic Institute at Walter Reed National Military Medical Center. We get under the hood of each FDA approved obesity medication plus some of our normal hijinks. Check out episode #23 for a more general overview of obesity. Full show notes available at http://thecurbsiders.com/podcast Join our newsletter mailing list. Rate us on iTunes, recommend a guest or topic and give feedback at [email protected]. Time Stamps 00:00 Intro 03:12 Picks of the week 08:44 Rapid fire questions 13:00 Counsel patients about obesity 14:40 Pathophysiology of obesity 18:00 Case 22:46 Phentermine/topiramate (Qsymia) 26:20 Bupropion/naltrexone (Contrave) 29:18 Liraglutide (Saxenda) 34:32 Orlistat (Alli, Xenical) 37:35 Cost issues 40:18 Lifelong medical therapy for obesity 42:44 Dr. Nadolsky’s take home points 44:45 The Curbsiders recap and discuss their experience with obesity medications 52:28 Outro Tags: assistant, care, doctor, education family, foam, foamed, health, hospitalist, hospital, internal, internist, nurse, medicine, medical, physician, practitioner, primary, resident, student, obesity, pharmacotherapy, weight loss, safety, side effects, orlistat, alli, naltrexone, bupropion, contrave, phentermine, topiramate, qsymia, lorcaserin, belviq, FDA